InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,425.20
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.33
(
-0.32%
)
Bitcoin
63,897.75
(
-0.58%
)
Post# of 813
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MaryMary158

Send PM Follow Ignore
Followers 2
Posts 219
Boards Moderated 0
Alias Born 05/04/2016

MaryMary158

Re: sorkin post# 302

Thursday, 12/05/2019 10:52:00 AM

Thursday, December 05, 2019 10:52:00 AM

Post# of 813
So will you address my question please? Here is more on yours.

Obviously we already have Rubraca which is growing internationally. Then we have the prostrate updated filing due before year-end. And...

Rubraca and sacituzumab combo inmTNBC, advanced urothelial cancer (UC) and second-line metastatic NSCLC. Preliminary readout of Clovis and IMMU collaboration may be presented at SABCS in few days.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up